Clinical trial
A Retrospective Assessment of OviTex PRS (OviTex) Permanent and Resorbable Devices in Subjects Who Have Previously Undergone a Breast Reconstruction
NCT05736848 is registered in ClinicalTrials.gov with Tela Bio Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Retrospective Assessment of OviTex PRS (OviTex) Permanent and Resorbable Devices in Subjects Who Have Previously Undergone a Breast Reconstruction
- Lead sponsor
- Tela Bio Inc
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- September 27, 2022
- Completion date
- December 31, 2026
- Enrollment
- 200 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
reconstructive surgical procedures